ICD-10 Diagnosis Code C67.9
Malignant neoplasm of bladder, unspecified
Diagnosis Code C67.9
Short Description: Malignant neoplasm of bladder, unspecified
Long Description: Malignant neoplasm of bladder, unspecified
This is the 2019 version of the ICD-10-CM diagnosis code C67.9
Valid for Submission
The code C67.9 is valid for submission for HIPAA-covered transactions.
Code Classification
Information for Medical Professionals
The diagnosis code C67.9 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)
- 656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
- 657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
- 658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC
- 659 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC
- 660 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC
- 661 - KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC
Convert to ICD-9
- 188.9 - Malig neo bladder NOS
Synonyms
- Adenocarcinoma of bladder
- Carcinoma of bladder
- Carcinoma of urinary bladder, invasive
- Carcinoma of urinary bladder, superficial
- Local recurrence of malignant tumor of urinary bladder
- Malignant neoplasm of augmented bladder
- Malignant tumor involving an organ by direct extension from bladder
- Malignant tumor involving an organ by separate metastasis from bladder
- Malignant tumor involving prostate by direct extension from bladder
- Malignant tumor involving prostate by separate metastasis from bladder
- Malignant tumor involving seminal vesicle by direct extension from bladder
- Malignant tumor involving seminal vesicle by separate metastasis from bladder
- Malignant tumor involving ureter by direct extension from bladder
- Malignant tumor involving ureter by separate metastasis from bladder
- Malignant tumor involving urethra by direct extension from bladder
- Malignant tumor involving urethra by separate metastasis from bladder
- Malignant tumor involving uterine corpus by direct extension from bladder
- Malignant tumor involving uterine corpus by separate metastasis from bladder
- Malignant tumor involving vagina by direct extension from bladder
- Malignant tumor involving vagina by separate metastasis from bladder
- Malignant tumor of seminal vesicle
- Malignant tumor of seminal vesicle
- Malignant tumor of urinary bladder
- Metastasis from malignant tumor of bladder
- Obstructive nephropathy due to bladder cancer
- Obstructive nephropathy due to malignancy
- pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension
- pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension
- pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension
- Primary malignant neoplasm of bladder
- Primary spindle cell carcinoma of urinary bladder
- pT1: Tumor invades subepithelial connective tissue
- pT2: Tumor invades muscularis propria
- pT2a: Tumor invades superficial muscle
- pT2b: Tumor invades deep muscle
- pT3: Tumor invades perivesical tissue
- pT3a: Tumor invades perivesical tissue microscopically
- pT3b: Tumor invades perivesical tissue macroscopically
- pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall
- pT4a: Tumor invades prostate or uterus or vagina
- pT4b: Tumor invades pelvic wall or abdominal wall
- pTa: Non-invasive papillary carcinoma
- Rhabdomyosarcoma of bladder
- Sarcoma of bladder
- Secondary malignant neoplasm of prostate
- Secondary malignant neoplasm of seminal vesicle
- Secondary malignant neoplasm of ureter
- Secondary malignant neoplasm of urethra
- Secondary malignant neoplasm of vagina
- Squamous cell carcinoma of bladder
- T2: Urinary bladder tumor invades muscle
- T2a: Urinary bladder tumor invades superficial muscle
- T2b: Urinary bladder tumor invades deep muscle
- T3: Urinary bladder tumor invades perivesical tissue
- T3a: Bladder tumor invades perivesical tissue microscopically
- T3b: Bladder tumor invades perivesical tissue macroscopically
- T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall
- T4a: Bladder tumor invades prostate or uterus or vagina
- T4b: Bladder tumor invades pelvic wall or abdominal wall
- Transitional cell carcinoma of bladder
- Tumor of seminal vesicle
- Tumor of seminal vesicle
Table of Neoplasms
The code C67.9 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
The Tabular must be reviewed for the complete diagnosis code.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »bladder (urinary) | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
| »bladder (urinary) »orifice | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
| »bladder (urinary) »wall | C67.9 | C79.11 | D09.0 | D30.3 | D41.4 | D49.4 |
Information for Patients
Bladder Cancer
The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.
Symptoms include
- Blood in your urine
- A frequent urge to urinate
- Pain when you urinate
- Low back pain
Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.
Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.
NIH: National Cancer Institute
- Bladder biopsy (Medical Encyclopedia)
- Bladder cancer (Medical Encyclopedia)
- Cancer - renal pelvis or ureter (Medical Encyclopedia)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)
[Read More]
Bladder cancer Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply without control or order. The bladder is a hollow, muscular organ in the lower abdomen that stores urine until it is ready to be excreted from the body. The most common type of bladder cancer begins in cells lining the inside of the bladder and is called transitional cell carcinoma (TCC).Bladder cancer may cause blood in the urine, pain during urination, frequent urination, or the feeling that one needs to urinate without results. These signs and symptoms are not specific to bladder cancer, however. They also can be caused by noncancerous conditions such as infections.
[Read More]
ICD-10 Footnotes
General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.